Chistats Labs Profile
Key Indicators
- Authorised Capital ₹ 0.12 M
- Paid Up Capital ₹ 59.81 K
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 277.69%
- Profit Growth 140.77%
- Ebitda 152.79%
- Net Worth 122.09%
- Total Assets 208.13%
About Chistats Labs
Chistats Labs Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 2019 (Six years and one month 14 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.12 M and a paid-up capital of Rs 59.81 K , as per Ministry of Corporate Affairs (MCA) records.
Rahul Lahane and Yogesh Karpate serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900PN2019PTC181311
- Company No.
181311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Chistats Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Lahane  | Director | 10-Jan-2019 | Current |
| Yogesh Karpate | Director | 10-Jan-2019 | Current |
Financial Performance of Chistats Labs.
Chistats Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 277.69% increase. The company also saw a substantial improvement in profitability, with a 140.77% increase in profit. The company's net worth Soared by an impressive increase of 122.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chistats Labs?
In 2023, Chistats Labs had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vroomble Services Private LimitedRahul Lahane is a mutual person
Guardinger Advanced Technologies Private LimitedYogesh Karpate is a mutual person
- Guardinger Technologies (Opc) Private Limited
Yogesh Karpate is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chistats Labs?
Unlock and access historical data on people associated with Chistats Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chistats Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chistats Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.